Driehaus Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,631
| Closed | -$286K | – | 502 |
|
|
2025
Q1 | $286K | Sell |
18,631
-2,967,480
| -99% | -$45.6M | ﹤0.01% | 382 |
|
|
2024
Q4 | $65.8M | Sell |
2,986,111
-625,392
| -17% | -$13.8M | 0.54% | 50 |
|
|
2024
Q3 | $65.1M | Buy |
3,611,503
+2,189,020
| +154% | +$39.4M | 0.56% | 50 |
|
|
2024
Q2 | $23.1M | Buy |
+1,422,483
| New | +$23.1M | 0.22% | 124 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 575 |
|
|
2016
Q2 | – | Sell |
-20,000
| Closed | -$1.07M | – | 611 |
|
|
2016
Q1 | $1.07M | Buy |
+20,000
| New | +$1.07M | 0.03% | 363 |
|
|
2015
Q4 | – | Sell |
-325,469
| Closed | -$18.4M | – | 604 |
|
|
2015
Q3 | $18.4M | Buy |
325,469
+200,469
| +160% | +$11.3M | 0.66% | 31 |
|
|
2015
Q2 | $7.39M | Buy |
+125,000
| New | +$7.39M | 0.26% | 88 |
|
|
2015
Q1 | – | Sell |
-28,089
| Closed | -$1.62M | – | 531 |
|
|
2014
Q4 | $1.62M | Buy |
28,089
+473
| +2% | +$27.2K | 0.07% | 349 |
|
|
2014
Q3 | $1.48M | Sell |
27,616
-7,544
| -21% | -$405K | 0.06% | 379 |
|
|
2014
Q2 | $1.84M | Buy |
35,160
+8,496
| +32% | +$445K | 0.06% | 361 |
|
|
2014
Q1 | $1.41M | Buy |
+26,664
| New | +$1.41M | 0.04% | 365 |
|